 | Up a level |
Hykin, Philip G; Staurenghi, Giovanni; Wiedemann, Peter; Wolf, Sebastian; Liew, Shiao Hui Melissa; Desset-Brethes, Sabine; Staines, Harry; Li, Jun; Lai, Timothy Y Y (2021). RANIBIZUMAB 0.5 MG TREATMENT IN ADOLESCENTS WITH CHOROIDAL NEOVASCULARIZATION: SUBGROUP ANALYSIS DATA FROM THE MINERVA STUDY. Retinal Cases & Brief Reports, 15(4), pp. 348-355. Lippincott Williams & Wilkins 10.1097/ICB.0000000000000825
Staurenghi, Giovanni; Lai, Timothy Y Y; Mitchell, Paul; Wolf, Sebastian; Wenzel, Andreas; Li, Jun; Bhaumik, Amitabha; Hykin, Philip G (2019). Reply. Ophthalmology, 126(6), e45-e46. Elsevier 10.1016/j.ophtha.2018.12.019
Staurenghi, Giovanni; Lai, Timothy Y Y; Mitchell, Paul; Wolf, Sebastian; Wenzel, Andreas; Li, Jun; Bhaumik, Amitabha; Hykin, Philip G (2019). Reply. Ophthalmology, 126(6), e43-e44. Elsevier 10.1016/j.ophtha.2018.12.021
Staurenghi, Giovanni; Lai, Timothy Y Y; Mitchell, Paul; Wolf, Sebastian; Wenzel, Andreas; Li, Jun; Bhaumik, Amitabha; Hykin, Philip G (2018). Efficacy and Safety of Ranibizumab 0.5 mg for the Treatment of Macular Edema Resulting from Uncommon Causes: Twelve-Month Findings from PROMETHEUS. Ophthalmology, 125(6), pp. 850-862. Elsevier 10.1016/j.ophtha.2017.12.002
Cheung, Chui Ming Gemmy; Arnold, Jennifer J; Holz, Frank G; Park, Kyu Hyung; Lai, Timothy Y Y; Larsen, Michael; Mitchell, Paul; Ohno-Matsui, Kyoko; Chen, Shih-Jen; Wolf, Sebastian; Wong, Tien Yin (2017). Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management. Ophthalmology, 124(11), pp. 1690-1711. Elsevier 10.1016/j.ophtha.2017.04.028
